Novo Nordisk A/S (NVO)
59.57
-0.29
(-0.48%)
USD |
NYSE |
Jan 13, 16:00
59.30
-0.27
(-0.45%)
After-Hours: 20:00
Novo Nordisk Market Cap: 264.70B for Jan. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ascendis Pharma A/S | 13.14B |
| Evaxion AS | 32.03M |
| Regeneron Pharmaceuticals, Inc. | 79.74B |
| Omeros Corp. | 894.06M |
| Viking Therapeutics, Inc. | 3.475B |
Market Cap Related Metrics
| PE Ratio | 17.35 |
| PS Ratio | 5.683 |
| PEG Ratio | 1.533 |
| Price to Book Value | 13.06 |
| Price to Free Cash Flow | 28.70 |
| Price | 59.57 |
| Earnings Yield | 5.76% |
| PEGY Ratio | 1.221 |
| Operating PE Ratio | 13.40 |
| Normalized PE Ratio | 17.35 |